How to Better Establish Clinical Utility for Tests in Personalized Medicine
Video Categories: Personalized MedicineRelated Videos

Exploring the Uses of Fulvestrant
Dr Sibylle Loibl explains how fulvestrant (with or without palbociclib) fits in the treatment paradigm for patients with HR+/ HER2-negative metastatic breast cancer.

HR+/HER2- Metastatic Breast Cancer: Common Presenting Symptoms
Hope Rugo, MD, discusses common presenting symptoms of HR+/HER2- metastatic breast cancer, citing bone metastasis as the most prevalent.